Spotlight on JLABS

Apr 6 2017

Come one, come all! You are invited to learn more about some of the exciting companies creating scientific breakthroughs at JLABS in Toronto. JLABS @ Toronto officially opened in May and currently has 41 companies with several more in the pipeline. Five companies will give candid, informative presentations detailing their executive teams, an overview of their company and highlighting their reasons for joining JLABS. Don't miss this opportunity to learn more about the progress of this exciting project and meet the companies within JLABS. Please note that the presentations at this event will include publicly available, non-confidential information only.

Thursday April 6th, 2017

10:30AM | Registration
11:00AM | Presentations
12:15PM | Q&A
12:30PM | Lunch & Networking
1:30pm | Program Close
* Light food and beverage provided

Presenting Companies:
Ardra Bio Inc. read more»
Biotagenics read more»
DNAstack read more»
NerveVision read more»
Tracery read more»

Please RSVP online so that we can get an accurate headcount for food and beverages. We will not be accepting walk-ups once the event is sold out.

JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Presenting Companies' Descriptions:

Ardra Bio Inc.
Ardra is a synthetic biology start-up targeting natural cosmetics, and flavour and fragrance industry. Ardra’s technology uses synthetic biology to develop biocatalysts for production of specialty chemicals from natural and renewable raw material. Their platform technology, based on designer pathways, allows Ardra to rapidly develop easy-to-scale-up processes with high yield, thereby bringing down the production cost of natural ingredients.

Biotagenics is a clinical microbiomics company developing therapeutics and companion diagnostics for the management and treatment of diseases associated with microbiota dysbiosis, with an initial focus on Inflammatory Bowel Disease. Biotagenics is identifying therapeutic targets that have the potential to restore symbiosis and modify the course of the disease. Our therapeutic strategy is based on precision targeting of the microbiome using our validated recombinant antibody platform.

Finding the genetic causes of disease has been described as trying to find a needle in a haystack. DNAstack’s mission is to develop cutting-edge technologies that help scientists discover and treat the causes of genetic diseases. DNAstack is a cloud-based genomics platform that helps geneticists securely manage, analyze, search, and share genomic datasets in the cloud.

NerveVision is an FDA (510k) cleared, medical imaging software platform for visualizing nerves in 3D from a standard MRI acquisition. This “disruptive” technology enables a Physician or Surgeon to see the nerve(s) path, integrity as well as areas of inflammation – assessing the nature of the problem prior to performing any treatment or surgical procedure. It addresses the Diagnostic, Pre-Surgical Planning and Minimally-Invasive surgery markets.

Tracery is a clinical stage ocular imaging and health tech company focused on Age Relate Macular Degeneration and blinding eye disease.